MyFinsight
Home
Blog
About
Cash and cash
equivalents
$11,242,068
(26.30%↑ Y/Y)
Prepaid expenses and
other current assets
$5,238,312
(-17.08%↓ Y/Y)
Inventory
$5,043,530
(22.22%↑ Y/Y)
Accounts receivable
$1,644,291
(-6.12%↓ Y/Y)
Total current assets
$23,168,201
(9.82%↑ Y/Y)
Equity method
investment
$2,527,418
(326.50%↑ Y/Y)
Other assets
$304,048
(-34.53%↓ Y/Y)
Operating lease
right-of-use assets, net
$185,183
(-22.28%↓ Y/Y)
Total assets
$26,184,850
(16.94%↑ Y/Y)
Accumulated deficit
-$653,540,250
(-10.32%↓ Y/Y)
Total liabilities and
stockholders' deficit
$26,184,850
(16.94%↑ Y/Y)
Total stockholders'
deficit
-$10,392,567
(72.06%↑ Y/Y)
Additional paid-in capital
$641,276,712
(15.59%↑ Y/Y)
Common stock, par value
0.01 per share...
$1,870,971
(330.32%↑ Y/Y)
Total liabilities
$36,577,417
(-38.61%↓ Y/Y)
Total current
liabilities
$28,679,051
(-8.92%↓ Y/Y)
Warrant liability
$7,758,238
(4.12%↑ Y/Y)
Operating lease
liabilities
$140,128
(-31.36%↓ Y/Y)
Current portion of
unsecured promissory note
$18,227,000
Accounts payable
$6,807,296
(-33.67%↓ Y/Y)
Accrued expenses
$3,278,739
(-38.30%↓ Y/Y)
Income taxes payable
$302,000
(-83.73%↓ Y/Y)
Current portion of
operating lease...
$64,016
(13.18%↑ Y/Y)
Back
Back
Balance Sheet
Outlook Therapeutics, Inc. (OTLK)
Outlook Therapeutics, Inc. (OTLK)
source: myfinsight.com